NACHC asks HRSA to pause Amgen’s new 340B data policy
Issue
On October 22, 2026, 340B Report reported that the National Association of Community Health Centers asked HRSA to direct Amgen to pause its new 340B data policy pending federal review. The outlet describes the group as a national trade group representing more than 1,500 community health centers.
Sources for this story
340B Report (October 22, 2026), reporting on a National Association of Community Health Centers request to HRSAPart of
- 340B drug pricing
Manufacturer restrictions and data demands
Sources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
More in Lobbying & Advocacy
FQHC Talent. (2026, October 22). NACHC asks HRSA to pause Amgen’s new 340B data policy. Source: 340B Report (October 22, 2026), reporting on a National Association of Community Health Centers request to HRSA. Retrieved November 11, 2026, from https://www.fqhctalent.com/intel/nachc-asks-hrsa-to-pause-amgen-340b-data-policy-october-2026